A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers

Clinical trial NCT05403554 · RECRUITING

Trial details

NCT number: NCT05403554
Sponsor: Light Chain Bioscience - Novimmune SA
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Triple Negative Breast Cancer Non-squamous Non-small-cell Lung Cancer Pancreatic Adenocarcinoma (ductal Adenocarcinoma)Endometrioid Ovarian Cancer

Start date: 2022-04-29
Primary completion: 2026-05-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.